Kristine Jahne
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Type I interferon drives T cell responses to amyloid beta in the central nervous system.
Journal: Nature communications
Published: October 23, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.
Journal: Science immunology
Published: May 03, 2024
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient.
Journal: Science advances
Published: February 02, 2024
Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases.
Journal: Cancer research communications
Published: January 11, 2024
A H3K27M-targeted vaccine in adults with diffuse midline glioma.
Journal: Nature medicine
Published: February 23, 2023
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors.
Journal: Cancer cell
Published: May 10, 2022
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles.
Journal: Nature communications
Published: May 06, 2022
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes.
Journal: Neuro-oncology advances
Published: November 05, 2021
Activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1 (Arc/Arg3.1) enhances dendritic cell vaccination in experimental melanoma.
Journal: Oncoimmunology
Published: May 24, 2021
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Journal: Nature communications
Published: November 25, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026